Patient Income Level and Cancer Clinical Trial Participation
- 10 February 2013
- journal article
- research article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 31 (5), 536-542
- https://doi.org/10.1200/jco.2012.45.4553
Abstract
Purpose Studies have shown an association between socioeconomic status (SES) and quality of oncology care, but less is known about the impact of patient SES on clinical trial participation. Patients and Methods We assessed clinical trial participation patterns according to important SES (income, education) and demographic factors in a large sample of patients surveyed via an Internet-based treatment decision tool. Logistic regression, conditioning on type of cancer, was used. Attitudes toward clinical trials were assessed using prespecified items about treatment, treatment tolerability, convenience, and cost. Results From 2007 to 2011, 5,499 patients were successfully surveyed. Forty percent discussed clinical trials with their physician, 45% of discussions led to physician offers of clinical trial participation, and 51% of offers led to clinical trial participation. The overall clinical trial participation rate was 9%. In univariate models, older patients (P = .002) and patients with lower income (P = .001) and education (P = .02) were less likely to participate in clinical trials. In a multivariable model, income remained a statistically significant predictor of clinical trial participation (odds ratio, 0.73; 95% CI, 0.57 to 0.94; P = .01). Even in patients age ≥ 65 years, who have universal access to Medicare, lower income predicted lower trial participation. Cost concerns were much more evident among lower-income patients (P < .001). Conclusion Lower-income patients were less likely to participate in clinical trials, even when considering age group. A better understanding of why income is a barrier may help identify ways to make clinical trials better available to all patients and would increase the generalizability of clinical trial results across all income levels.Keywords
This publication has 45 references indexed in Scilit:
- Impact of the Cost of Cancer Treatment: An Internet-Based SurveyJournal of Oncology Practice, 2010
- Drug costs and out-of-pocket spending in cancer clinical trialsContemporary Clinical Trials, 2008
- A Decade of Direct-to-Consumer Advertising of Prescription DrugsThe New England Journal of Medicine, 2007
- Evaluation of Factors Affecting Awareness of and Willingness to Participate in Cancer Clinical TrialsJournal of Clinical Oncology, 2005
- Predictors of enrollment in lung cancer clinical trialsCancer, 2005
- Clinical trial participation among patients enrolled in the Glioma Outcomes ProjectCancer, 2002
- Socio-Economic Status and Inducement to ParticipateAmerican Journal of Bioethics, 2001
- Underrepresentation of Patients 65 Years of Age or Older in Cancer-Treatment TrialsThe New England Journal of Medicine, 1999
- SURVEY RESEARCHAnnual Review of Psychology, 1999
- Influence of age and comorbidity on treatment choice and survival in elderly patients with breast cancerBreast Cancer Research and Treatment, 1991